Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular vaccine therapy for cancer.

Anne C Armstrong1, David Eaton, Joanne C Ewing

  • 1Department of Medical Oncology, Paterson Institute of Cancer Research, Christie Hospital NHS Trust, Manchester, UK. Aarmstrong@picr.man.ac.uk

Expert Review of Vaccines
|August 7, 2003
PubMed
Summary

Cancer immunotherapy, using immune cells as a therapeutic vaccine, shows promise. Harnessing dendritic cells and gene therapy may optimize immune responses for effective cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pregnancy Associated Breast Cancer: An Australian Perspective.

ANZ journal of surgery·2025
Same author

Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial.

Nature communications·2025
Same author

Automated contouring and radiotherapy treatment planning of spine metastases using atlas-based auto-segmentation and knowledge-based planning approaches.

The British journal of radiology·2025
Same author

Autocontouring of primary lung lesions and nodal disease for radiotherapy based only on computed tomography images.

Physics and imaging in radiation oncology·2024
Same author

Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer.

JCO precision oncology·2024
Same author

The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.

Nature·2024

Area of Science:

  • Immunology
  • Oncology
  • Gene Therapy

Background:

  • Immune cells demonstrate the ability to eliminate tumor cells in laboratory and animal studies.
  • This observation supports the development of immune cell-based therapies for cancer treatment.
  • Effective cancer immunotherapy requires eliciting a potent immune response.

Purpose of the Study:

  • To explore the potential of using immune cells as a therapeutic vaccine for cancer.
  • To investigate methods for optimizing immune responses in cancer immunotherapy.
  • To assess the efficacy of dendritic cell-based and gene therapy approaches in cancer management.

Main Methods:

  • Utilizing immune cells for therapeutic vaccination in cancer patients.
  • Harnessing the immune-priming capabilities of dendritic cells.
  • Employing gene therapy techniques to enhance immune responses.

Main Results:

  • In vitro and animal models show immune cells can kill tumor cells.
  • Dendritic cells are key in initiating immune responses.
  • Gene therapy can optimize immune responses for cancer treatment.

Conclusions:

  • Administering immune cells as a therapeutic vaccine is a viable strategy for cancer.
  • Dendritic cell and gene therapy approaches hold promise for optimizing cancer immunotherapy.
  • Recent clinical trials indicate this approach may be an effective treatment for human cancers.

Related Experiment Videos